 | • レポートコード：MRC2-11QY12694 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は軽度・中等度アトピー性皮膚炎治療のグローバル市場について調査・分析したレポートです。種類別（放射線治療、薬物治療）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別軽度・中等度アトピー性皮膚炎治療の競争状況、市場シェア ・世界の軽度・中等度アトピー性皮膚炎治療市場：種類別市場規模 2015年-2020年（放射線治療、薬物治療） ・世界の軽度・中等度アトピー性皮膚炎治療市場：種類別市場規模予測 2021年-2026年（放射線治療、薬物治療） ・世界の軽度・中等度アトピー性皮膚炎治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の軽度・中等度アトピー性皮膚炎治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の軽度・中等度アトピー性皮膚炎治療市場分析：米国、カナダ ・ヨーロッパの軽度・中等度アトピー性皮膚炎治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの軽度・中等度アトピー性皮膚炎治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の軽度・中等度アトピー性皮膚炎治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの軽度・中等度アトピー性皮膚炎治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Pfizer、Sanofi、Anacor Pharmaceuticals、Astellas Pharma、Meda Pharmaceuticals、Regeneron Pharmaceuticals、Bausch Health ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Mild-to-moderate atopic dermatitis is a chronic inflammatory skin disease often confined to the flexural surfaces of the body and usually begins in childhood.
Drug treatment can further be segmented into antihistamines, antibiotics, emollients, corticosteroids, and calcineurin inhibitors.
Market Analysis and Insights: Global Mild-to-Moderate Atopic Dermatitis Treatment Market
The global Mild-to-Moderate Atopic Dermatitis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Mild-to-Moderate Atopic Dermatitis Treatment Scope and Market Size
Mild-to-Moderate Atopic Dermatitis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Mild-to-Moderate Atopic Dermatitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Novartis
Pfizer
Sanofi
Anacor Pharmaceuticals
Astellas Pharma
Meda Pharmaceuticals
Regeneron Pharmaceuticals
Bausch Health
Market segment by Type, the product can be split into
Radiation Treatment
Drug Treatment
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Mild-to-Moderate Atopic Dermatitis Treatment Revenue
1.4 Market by Type
1.4.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Radiation Treatment
1.4.3 Drug Treatment
1.5 Market by Application
1.5.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Perspective (2015-2026)
2.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Growth Trends by Regions
2.2.1 Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Mild-to-Moderate Atopic Dermatitis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Mild-to-Moderate Atopic Dermatitis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Mild-to-Moderate Atopic Dermatitis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Mild-to-Moderate Atopic Dermatitis Treatment Players by Market Size
3.1.1 Global Top Mild-to-Moderate Atopic Dermatitis Treatment Players by Revenue (2015-2020)
3.1.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Concentration Ratio
3.2.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Mild-to-Moderate Atopic Dermatitis Treatment Revenue in 2019
3.3 Mild-to-Moderate Atopic Dermatitis Treatment Key Players Head office and Area Served
3.4 Key Players Mild-to-Moderate Atopic Dermatitis Treatment Product Solution and Service
3.5 Date of Enter into Mild-to-Moderate Atopic Dermatitis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020)
5.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2015-2020)
6.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players in North America (2019-2020)
6.3 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020)
6.4 North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2015-2020)
7.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players in Europe (2019-2020)
7.3 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020)
7.4 Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2015-2020)
8.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players in China (2019-2020)
8.3 China Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020)
8.4 China Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2015-2020)
9.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players in Japan (2019-2020)
9.3 Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020)
9.4 Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2015-2020)
10.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2015-2020)
11.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players in India (2019-2020)
11.3 India Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020)
11.4 India Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Size (2015-2020)
12.2 Mild-to-Moderate Atopic Dermatitis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Mild-to-Moderate Atopic Dermatitis Treatment Introduction
13.1.4 Novartis Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Mild-to-Moderate Atopic Dermatitis Treatment Introduction
13.2.4 Pfizer Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview
13.3.3 Sanofi Mild-to-Moderate Atopic Dermatitis Treatment Introduction
13.3.4 Sanofi Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020)
13.3.5 Sanofi Recent Development
13.4 Anacor Pharmaceuticals
13.4.1 Anacor Pharmaceuticals Company Details
13.4.2 Anacor Pharmaceuticals Business Overview
13.4.3 Anacor Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Introduction
13.4.4 Anacor Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020)
13.4.5 Anacor Pharmaceuticals Recent Development
13.5 Astellas Pharma
13.5.1 Astellas Pharma Company Details
13.5.2 Astellas Pharma Business Overview
13.5.3 Astellas Pharma Mild-to-Moderate Atopic Dermatitis Treatment Introduction
13.5.4 Astellas Pharma Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020)
13.5.5 Astellas Pharma Recent Development
13.6 Meda Pharmaceuticals
13.6.1 Meda Pharmaceuticals Company Details
13.6.2 Meda Pharmaceuticals Business Overview
13.6.3 Meda Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Introduction
13.6.4 Meda Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020)
13.6.5 Meda Pharmaceuticals Recent Development
13.7 Regeneron Pharmaceuticals
13.7.1 Regeneron Pharmaceuticals Company Details
13.7.2 Regeneron Pharmaceuticals Business Overview
13.7.3 Regeneron Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Introduction
13.7.4 Regeneron Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020)
13.7.5 Regeneron Pharmaceuticals Recent Development
13.8 Bausch Health
13.8.1 Bausch Health Company Details
13.8.2 Bausch Health Business Overview
13.8.3 Bausch Health Mild-to-Moderate Atopic Dermatitis Treatment Introduction
13.8.4 Bausch Health Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020)
13.8.5 Bausch Health Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Mild-to-Moderate Atopic Dermatitis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Mild-to-Moderate Atopic Dermatitis Treatment Revenue
Table 3. Ranking of Global Top Mild-to-Moderate Atopic Dermatitis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Radiation Treatment
Table 6. Key Players of Drug Treatment
Table 7. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Regions (2015-2020)
Table 11. Global Mild-to-Moderate Atopic Dermatitis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Mild-to-Moderate Atopic Dermatitis Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Mild-to-Moderate Atopic Dermatitis Treatment Players
Table 18. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Players (2015-2020)
Table 20. Global Top Mild-to-Moderate Atopic Dermatitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mild-to-Moderate Atopic Dermatitis Treatment as of 2019)
Table 21. Global Mild-to-Moderate Atopic Dermatitis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Mild-to-Moderate Atopic Dermatitis Treatment Product Solution and Service
Table 24. Date of Enter into Mild-to-Moderate Atopic Dermatitis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Share by Type (2015-2020)
Table 28. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Share by Application (2015-2020)
Table 30. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Mild-to-Moderate Atopic Dermatitis Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Mild-to-Moderate Atopic Dermatitis Treatment Market Share (2019-2020)
Table 34. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2015-2020)
Table 36. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Mild-to-Moderate Atopic Dermatitis Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Mild-to-Moderate Atopic Dermatitis Treatment Market Share (2019-2020)
Table 40. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2015-2020)
Table 42. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Mild-to-Moderate Atopic Dermatitis Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Mild-to-Moderate Atopic Dermatitis Treatment Market Share (2019-2020)
Table 46. China Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2015-2020)
Table 48. China Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Mild-to-Moderate Atopic Dermatitis Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Mild-to-Moderate Atopic Dermatitis Treatment Market Share (2019-2020)
Table 52. Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2015-2020)
Table 54. Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Mild-to-Moderate Atopic Dermatitis Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Mild-to-Moderate Atopic Dermatitis Treatment Market Share (2019-2020)
Table 58. Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Mild-to-Moderate Atopic Dermatitis Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Mild-to-Moderate Atopic Dermatitis Treatment Market Share (2019-2020)
Table 64. India Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2015-2020)
Table 66. India Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Mild-to-Moderate Atopic Dermatitis Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Mild-to-Moderate Atopic Dermatitis Treatment Market Share (2019-2020)
Table 70. Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application (2015-2020)
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Product
Table 77. Novartis Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020) (Million US$)
Table 78. Novartis Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi Product
Table 87. Sanofi Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020) (Million US$)
Table 88. Sanofi Recent Development
Table 89. Anacor Pharmaceuticals Company Details
Table 90. Anacor Pharmaceuticals Business Overview
Table 91. Anacor Pharmaceuticals Product
Table 92. Anacor Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020) (Million US$)
Table 93. Anacor Pharmaceuticals Recent Development
Table 94. Astellas Pharma Company Details
Table 95. Astellas Pharma Business Overview
Table 96. Astellas Pharma Product
Table 97. Astellas Pharma Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020) (Million US$)
Table 98. Astellas Pharma Recent Development
Table 99. Meda Pharmaceuticals Company Details
Table 100. Meda Pharmaceuticals Business Overview
Table 101. Meda Pharmaceuticals Product
Table 102. Meda Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020) (Million US$)
Table 103. Meda Pharmaceuticals Recent Development
Table 104. Regeneron Pharmaceuticals Company Details
Table 105. Regeneron Pharmaceuticals Business Overview
Table 106. Regeneron Pharmaceuticals Product
Table 107. Regeneron Pharmaceuticals Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020) (Million US$)
Table 108. Regeneron Pharmaceuticals Recent Development
Table 109. Bausch Health Business Overview
Table 110. Bausch Health Product
Table 111. Bausch Health Company Details
Table 112. Bausch Health Revenue in Mild-to-Moderate Atopic Dermatitis Treatment Business (2015-2020) (Million US$)
Table 113. Bausch Health Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Radiation Treatment Features
Figure 3. Drug Treatment Features
Figure 4. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Mild-to-Moderate Atopic Dermatitis Treatment Report Years Considered
Figure 9. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Share by Players in 2019
Figure 14. Global Top Mild-to-Moderate Atopic Dermatitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mild-to-Moderate Atopic Dermatitis Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Mild-to-Moderate Atopic Dermatitis Treatment Revenue in 2019
Figure 16. North America Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Mild-to-Moderate Atopic Dermatitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
犬アトピー性皮膚炎治療の世界市場（～2026年） Canine atopic dermatitis is a problem that is related to the skin, which when exposed to the allergens results in allergic symptoms. Market Analysis and Insights: Global Canine Atopic Dermatitis Treatment Market The global Canine Atopic Dermatitis Treatment market size is projected to reach US$ XX m…- 放射線皮膚炎治療の世界市場（～2026年） The pathophysiology of a radiation skin reaction is a combination of radiation injury and the subsequent inflammatory response and can occur at both the entrance and exit site of the irradiation. The major factor driving the radiation dermatitis treatment market is the increasing prevalence of cance…
- 脂漏性皮膚炎治療の世界市場（～2026年） Seborrhoeic dermatitis is a long-term skin disorder. Seborrhoeic dermatitis symptoms include red, scaly, greasy, itchy and inflamed skin. Market Analysis and Insights: Global Seborrheic Dermatitis Treatment Market The global Seborrheic Dermatitis Treatment market size is projected to reach US$ XX mi…
- アトピー性皮膚炎薬の世界市場（～2026年） Atopic dermatitis (AD) is a pruritic disease of unknown origin that usually starts in early infancy (an adult-onset variant is recognized). One of the major factors responsible for the growing risk of severe atopic dermatitis in infancy is related to food sensitization, which is commonly associated …
- 高カルシウム血症治療の世界市場（～2026年） Hypercalcemia is a condition caused by above normal levels of calcium in the body, with serum calcium level greater than 2.6 mmol/L. It is a life threatening metabolic disorder associated with neoplastic diseases and occurs in 10% to 20% of all adults suffering from cancer; particularly lung and bre…